Buscar resultados de ensayos clínicos
Medulloblastoma - 42 Studies Found
| Estado | Estudiar |
| Recruiting |
Nombre del estudio: WEE1 Inhibitor MK-1775 and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors Condición:
|
| Recruiting |
Nombre del estudio: Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery Condición: Brain and Central Nervous System Tumors Fecha: 2006-01-12 Intervenciones:
|
| Completed |
Nombre del estudio: Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma Condición:
Fecha: 1999-11-01 Intervenciones:
|
| Completed |
Nombre del estudio: Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma Condición:
Fecha: 1999-11-01 Intervenciones:
|
| Completed |
Nombre del estudio: Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) Condición:
|
| Active, not recruiting |
Nombre del estudio: Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma Condición: Brain and Central Nervous System Tumors Fecha: 2003-04-07 Intervenciones:
|
| Completed |
Nombre del estudio: Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors Condición: Brain and Central Nervous System Tumors Fecha: 2001-10-11 Intervenciones:
|
| Completed |
Nombre del estudio: A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss Condición: Medulloblastoma Fecha: 2026-01-11 Intervenciones: Given IV |
| COMPLETED |
Nombre del estudio: Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Condición: Medulloblastoma Fecha: 2026-01-11 Intervenciones: Given IV |
| COMPLETED |
Nombre del estudio: Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor Condición: Medulloblastoma Fecha: 2026-01-11 Intervenciones: TTRNA-xALT 3 x 10^7/kg by intravenous injection once. |